US Stock MarketDetailed Quotes

SYRS Syros Pharmaceuticals

Watchlist
  • 2.4300
  • +0.1650+7.28%
Close Nov 4 16:00 ET
  • 2.3500
  • -0.0800-3.29%
Post 18:13 ET
65.20MMarket Cap-791P/E (TTM)

Syros Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
-33.23%9.94M
151.19%386K
-3.32%3.76M
-54.86%2.83M
-45.97%2.95M
-36.65%14.88M
-109.66%-754K
Operating revenue
--0
--0
--0
-33.23%9.94M
151.19%386K
-3.32%3.76M
-54.86%2.83M
-45.97%2.95M
-36.65%14.88M
-109.66%-754K
Cost of revenue
Gross profit
Operating expense
-27.36%26.18M
-25.57%27.42M
-14.50%30.92M
-3.40%136.44M
-22.28%27.39M
6.53%36.04M
-8.02%36.83M
12.60%36.17M
14.92%141.24M
6.07%35.24M
Selling and administrative expenses
-27.16%5.66M
-24.39%5.46M
-15.38%6.27M
-3.47%28.28M
-19.66%5.89M
-3.86%7.76M
4.03%7.23M
6.56%7.41M
27.19%29.3M
13.98%7.33M
-General and administrative expense
-27.16%5.66M
-24.39%5.46M
-15.38%6.27M
-3.47%28.28M
-19.66%5.89M
-3.86%7.76M
4.03%7.23M
6.56%7.41M
27.19%29.3M
13.98%7.33M
Research and development costs
-27.42%20.53M
-25.85%21.95M
-14.28%24.66M
-3.39%108.15M
-22.97%21.5M
9.79%28.28M
-10.55%29.61M
14.26%28.76M
12.09%111.94M
4.18%27.91M
Operating profit
18.90%-26.18M
19.36%-27.42M
6.90%-30.92M
-0.11%-126.5M
24.98%-27.01M
-7.81%-32.28M
-0.68%-34M
-24.61%-33.21M
-27.10%-126.36M
-41.59%-36M
Net non-operating interest income expense
-257.27%-519K
-135.06%-297K
-57.17%239K
184.37%1.69M
-109.85%-46K
150.08%330K
197.47%847K
159.30%558K
47.59%-2M
148.90%467K
Non-operating interest income
-51.44%793K
-48.94%1.09M
-12.90%1.55M
219.70%6.82M
-19.46%1.28M
316.58%1.63M
1,797.32%2.13M
4,971.43%1.78M
2,350.57%2.13M
5,038.71%1.59M
Non-operating interest expense
0.69%1.31M
8.14%1.38M
7.40%1.31M
24.02%5.13M
18.03%1.33M
23.98%1.3M
30.28%1.28M
24.69%1.22M
5.81%4.13M
14.20%1.13M
Other net income (expense)
347.89%20.31M
241.26%4.39M
204.28%26.97M
-217.96%-39.76M
-221.38%-37.33M
-2,440.29%-8.19M
-2,077.71%-3.11M
262.13%8.87M
102.08%33.71M
1,099.06%30.76M
Gain on sale of security
447.87%20.31M
241.26%4.39M
204.28%26.97M
-186.24%-37.28M
-220.95%-37.2M
-159.20%-5.84M
-2,077.71%-3.11M
262.13%8.87M
159.09%43.22M
1,099.06%30.76M
Special income (charges)
--0
----
----
73.83%-2.49M
---135K
75.25%-2.35M
----
----
---9.51M
--0
-Less：Restructuring and merger&acquisition
--0
----
----
-73.83%2.49M
--135K
-75.25%2.35M
----
----
--9.51M
--0
Income before tax
84.07%-6.4M
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
Income tax
Net income
84.07%-6.4M
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
Net income continuous Operations
84.07%-6.4M
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
Minority interest income
Net income attributable to the parent company
84.07%-6.4M
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
84.07%-6.4M
35.66%-23.33M
84.41%-3.71M
-73.87%-164.57M
-1,248.64%-64.38M
-32.69%-40.14M
-5.15%-36.26M
5.40%-23.79M
-9.35%-94.65M
79.95%-4.77M
Basic earnings per share
88.81%-0.16
54.62%-0.59
88.24%-0.1
22.43%-5.81
-842.28%-2.22
55.45%-1.43
75.93%-1.3
78.70%-0.85
45.88%-7.49
93.77%-0.2356
Diluted earnings per share
88.81%-0.16
54.62%-0.59
88.24%-0.1
22.43%-5.81
-842.28%-2.22
55.45%-1.43
75.93%-1.3
78.70%-0.85
45.88%-7.49
93.77%-0.2356
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 000-33.23%9.94M151.19%386K-3.32%3.76M-54.86%2.83M-45.97%2.95M-36.65%14.88M-109.66%-754K
Operating revenue --0--0--0-33.23%9.94M151.19%386K-3.32%3.76M-54.86%2.83M-45.97%2.95M-36.65%14.88M-109.66%-754K
Cost of revenue
Gross profit
Operating expense -27.36%26.18M-25.57%27.42M-14.50%30.92M-3.40%136.44M-22.28%27.39M6.53%36.04M-8.02%36.83M12.60%36.17M14.92%141.24M6.07%35.24M
Selling and administrative expenses -27.16%5.66M-24.39%5.46M-15.38%6.27M-3.47%28.28M-19.66%5.89M-3.86%7.76M4.03%7.23M6.56%7.41M27.19%29.3M13.98%7.33M
-General and administrative expense -27.16%5.66M-24.39%5.46M-15.38%6.27M-3.47%28.28M-19.66%5.89M-3.86%7.76M4.03%7.23M6.56%7.41M27.19%29.3M13.98%7.33M
Research and development costs -27.42%20.53M-25.85%21.95M-14.28%24.66M-3.39%108.15M-22.97%21.5M9.79%28.28M-10.55%29.61M14.26%28.76M12.09%111.94M4.18%27.91M
Operating profit 18.90%-26.18M19.36%-27.42M6.90%-30.92M-0.11%-126.5M24.98%-27.01M-7.81%-32.28M-0.68%-34M-24.61%-33.21M-27.10%-126.36M-41.59%-36M
Net non-operating interest income expense -257.27%-519K-135.06%-297K-57.17%239K184.37%1.69M-109.85%-46K150.08%330K197.47%847K159.30%558K47.59%-2M148.90%467K
Non-operating interest income -51.44%793K-48.94%1.09M-12.90%1.55M219.70%6.82M-19.46%1.28M316.58%1.63M1,797.32%2.13M4,971.43%1.78M2,350.57%2.13M5,038.71%1.59M
Non-operating interest expense 0.69%1.31M8.14%1.38M7.40%1.31M24.02%5.13M18.03%1.33M23.98%1.3M30.28%1.28M24.69%1.22M5.81%4.13M14.20%1.13M
Other net income (expense) 347.89%20.31M241.26%4.39M204.28%26.97M-217.96%-39.76M-221.38%-37.33M-2,440.29%-8.19M-2,077.71%-3.11M262.13%8.87M102.08%33.71M1,099.06%30.76M
Gain on sale of security 447.87%20.31M241.26%4.39M204.28%26.97M-186.24%-37.28M-220.95%-37.2M-159.20%-5.84M-2,077.71%-3.11M262.13%8.87M159.09%43.22M1,099.06%30.76M
Special income (charges) --0--------73.83%-2.49M---135K75.25%-2.35M-----------9.51M--0
-Less：Restructuring and merger&acquisition --0---------73.83%2.49M--135K-75.25%2.35M----------9.51M--0
Income before tax 84.07%-6.4M35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M
Income tax
Net income 84.07%-6.4M35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M
Net income continuous Operations 84.07%-6.4M35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M
Minority interest income
Net income attributable to the parent company 84.07%-6.4M35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 84.07%-6.4M35.66%-23.33M84.41%-3.71M-73.87%-164.57M-1,248.64%-64.38M-32.69%-40.14M-5.15%-36.26M5.40%-23.79M-9.35%-94.65M79.95%-4.77M
Basic earnings per share 88.81%-0.1654.62%-0.5988.24%-0.122.43%-5.81-842.28%-2.2255.45%-1.4375.93%-1.378.70%-0.8545.88%-7.4993.77%-0.2356
Diluted earnings per share 88.81%-0.1654.62%-0.5988.24%-0.122.43%-5.81-842.28%-2.2255.45%-1.4375.93%-1.378.70%-0.8545.88%-7.4993.77%-0.2356
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data